自我管理的家庭睡眠测试模式筛选OSA在医护人员- sohew研究：一项在越南的国家多中心研究。

IF 3 Q2 RESPIRATORY SYSTEM

Pulmonary Therapy Pub Date : 2025-09-27 DOI:10.1007/s41030-025-00315-0

Sy Duong-Quy, Thai Nguyen-Duy, Tran V Hoc, Lien Nguyen-Thi-Hong, Tram Tang-Thi-Thao, Khue Bui-Diem, Diep Nguyen-Thi-Hong, Bang Nguyen-Trong, Anh Nguyen-Tuan, Hoang Nguyen-Huu, Quan Vu-Tran-Thien, Toi Nguyen-Van, Trung Mai-Xuan, Viet Nguyen-Ba, Thu Vo-Pham-Minh-Thu, Thuc Pham-Van, Linh Pham-Van, Giap Vu-Van, Bao Le-Khac, Dung Nguyen-Thi-Thu, Khue Luong-Ngoc, Ngoc Luu-Bich, Thuy Tran-Phan-Chung, Huong Le-Thi-Minh, Vinh Nguyen-Nhu, Nhung Nguyen-Viet, Timothy Craig, Franck Soyez, Francis Martin, Thomas Penzel

{"title":"自我管理的家庭睡眠测试模式筛选OSA在医护人员- sohew研究：一项在越南的国家多中心研究。","authors":"Sy Duong-Quy, Thai Nguyen-Duy, Tran V Hoc, Lien Nguyen-Thi-Hong, Tram Tang-Thi-Thao, Khue Bui-Diem, Diep Nguyen-Thi-Hong, Bang Nguyen-Trong, Anh Nguyen-Tuan, Hoang Nguyen-Huu, Quan Vu-Tran-Thien, Toi Nguyen-Van, Trung Mai-Xuan, Viet Nguyen-Ba, Thu Vo-Pham-Minh-Thu, Thuc Pham-Van, Linh Pham-Van, Giap Vu-Van, Bao Le-Khac, Dung Nguyen-Thi-Thu, Khue Luong-Ngoc, Ngoc Luu-Bich, Thuy Tran-Phan-Chung, Huong Le-Thi-Minh, Vinh Nguyen-Nhu, Nhung Nguyen-Viet, Timothy Craig, Franck Soyez, Francis Martin, Thomas Penzel","doi":"10.1007/s41030-025-00315-0","DOIUrl":null,"url":null,"abstract":"Background: Sleep disorders, including snoring and obstructive sleep apnea (OSA), are significant health concerns. OSA affects an estimated 4 million (8.5%) individuals in Vietnam, with 2.3 million suffering from moderate-to-severe conditions. Despite the high prevalence, underdiagnosis and limited accessibility to sleep diagnostics remain challenges. This study aims to assess the feasibility and effectiveness of a guided, self-administered home sleep study using a level 3 diagnostic model.Methods: A cross-sectional multicenter survey conducted from September 2023 to March 2024 included healthcare professionals (HCPs) across Vietnam. Participants completed questionnaires (Epworth Sleepiness Scale, STOP-BANG), and high-risk individuals underwent respiratory polygraphy using ApneaLink Air devices. Standardized instructions and technical support were provided remotely by trained technicians.Results: Out of 1721 participants, 21.9% were diagnosed with OSA, comprising mild (32.4%), moderate (19.6%), and severe cases (9.2%). Prevalent symptoms included insomnia (22.2%), daytime sleepiness (40.7%), and memory decline (49.4%). Technical issues were minimal, supporting the feasibility of this approach.Conclusion: A level 3 home sleep study model is effective for large-scale OSA screening. Integrating such approaches into public health initiatives can enhance early diagnosis and treatment access, reducing OSA-related health and economic burdens. Graphical abstract available for this article.","PeriodicalId":20919,"journal":{"name":"Pulmonary Therapy","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Self-Administered Home Sleep Testing Model in Screening of OSA in Healthcare Workers-Sohew Study: A National Multicenter Study in Vietnam.\",\"authors\":\"Sy Duong-Quy, Thai Nguyen-Duy, Tran V Hoc, Lien Nguyen-Thi-Hong, Tram Tang-Thi-Thao, Khue Bui-Diem, Diep Nguyen-Thi-Hong, Bang Nguyen-Trong, Anh Nguyen-Tuan, Hoang Nguyen-Huu, Quan Vu-Tran-Thien, Toi Nguyen-Van, Trung Mai-Xuan, Viet Nguyen-Ba, Thu Vo-Pham-Minh-Thu, Thuc Pham-Van, Linh Pham-Van, Giap Vu-Van, Bao Le-Khac, Dung Nguyen-Thi-Thu, Khue Luong-Ngoc, Ngoc Luu-Bich, Thuy Tran-Phan-Chung, Huong Le-Thi-Minh, Vinh Nguyen-Nhu, Nhung Nguyen-Viet, Timothy Craig, Franck Soyez, Francis Martin, Thomas Penzel\",\"doi\":\"10.1007/s41030-025-00315-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Sleep disorders, including snoring and obstructive sleep apnea (OSA), are significant health concerns. OSA affects an estimated 4 million (8.5%) individuals in Vietnam, with 2.3 million suffering from moderate-to-severe conditions. Despite the high prevalence, underdiagnosis and limited accessibility to sleep diagnostics remain challenges. This study aims to assess the feasibility and effectiveness of a guided, self-administered home sleep study using a level 3 diagnostic model.Methods: A cross-sectional multicenter survey conducted from September 2023 to March 2024 included healthcare professionals (HCPs) across Vietnam. Participants completed questionnaires (Epworth Sleepiness Scale, STOP-BANG), and high-risk individuals underwent respiratory polygraphy using ApneaLink Air devices. Standardized instructions and technical support were provided remotely by trained technicians.Results: Out of 1721 participants, 21.9% were diagnosed with OSA, comprising mild (32.4%), moderate (19.6%), and severe cases (9.2%). Prevalent symptoms included insomnia (22.2%), daytime sleepiness (40.7%), and memory decline (49.4%). Technical issues were minimal, supporting the feasibility of this approach.Conclusion: A level 3 home sleep study model is effective for large-scale OSA screening. Integrating such approaches into public health initiatives can enhance early diagnosis and treatment access, reducing OSA-related health and economic burdens. Graphical abstract available for this article.\",\"PeriodicalId\":20919,\"journal\":{\"name\":\"Pulmonary Therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pulmonary Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s41030-025-00315-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s41030-025-00315-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

摘要

背景：睡眠障碍，包括打鼾和阻塞性睡眠呼吸暂停（OSA），是重要的健康问题。据估计，越南有400万人（8.5%）患有阻塞性睡眠呼吸暂停症，其中230万人患有中度至重度疾病。尽管患病率很高，但诊断不足和睡眠诊断的可及性有限仍然是挑战。本研究旨在评估使用三级诊断模型进行自我指导的家庭睡眠研究的可行性和有效性。方法：一项横断面多中心调查于2023年9月至2024年3月进行，包括越南各地的卫生保健专业人员（HCPs）。参与者完成问卷调查（Epworth嗜睡量表，STOP-BANG），高危人群使用ApneaLink Air设备进行呼吸测谎。标准化的指导和技术支持由训练有素的技术人员远程提供。结果：在1721名参与者中，21.9%被诊断为OSA，包括轻度（32.4%）、中度（19.6%）和重度（9.2%）。常见症状包括失眠（22.2%）、白天嗜睡（40.7%）和记忆力下降（49.4%）。技术问题很少，支持这种方法的可行性。结论：3级家庭睡眠研究模式对OSA的大规模筛查是有效的。将这些方法纳入公共卫生举措可以加强早期诊断和治疗机会，减少与asa相关的健康和经济负担。本文提供图形摘要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Self-Administered Home Sleep Testing Model in Screening of OSA in Healthcare Workers-Sohew Study: A National Multicenter Study in Vietnam.

Background: Sleep disorders, including snoring and obstructive sleep apnea (OSA), are significant health concerns. OSA affects an estimated 4 million (8.5%) individuals in Vietnam, with 2.3 million suffering from moderate-to-severe conditions. Despite the high prevalence, underdiagnosis and limited accessibility to sleep diagnostics remain challenges. This study aims to assess the feasibility and effectiveness of a guided, self-administered home sleep study using a level 3 diagnostic model.

Methods: A cross-sectional multicenter survey conducted from September 2023 to March 2024 included healthcare professionals (HCPs) across Vietnam. Participants completed questionnaires (Epworth Sleepiness Scale, STOP-BANG), and high-risk individuals underwent respiratory polygraphy using ApneaLink Air devices. Standardized instructions and technical support were provided remotely by trained technicians.

Results: Out of 1721 participants, 21.9% were diagnosed with OSA, comprising mild (32.4%), moderate (19.6%), and severe cases (9.2%). Prevalent symptoms included insomnia (22.2%), daytime sleepiness (40.7%), and memory decline (49.4%). Technical issues were minimal, supporting the feasibility of this approach.

Conclusion: A level 3 home sleep study model is effective for large-scale OSA screening. Integrating such approaches into public health initiatives can enhance early diagnosis and treatment access, reducing OSA-related health and economic burdens. Graphical abstract available for this article.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pulmonary Therapy Medicine-Pulmonary and Respiratory Medicine

CiteScore

5.20

自引率

3.30%

发文量

审稿时长

6 weeks

期刊介绍： Aims and Scope Pulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the use of pulmonary therapies, devices, and surgical techniques. Areas of focus include, but are not limited to: asthma; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; pulmonary hypertension; cystic fibrosis; lung cancer; respiratory tract disorders; allergic rhinitis and other respiratory allergies; influenza, pneumococcal infection, respiratory syncytial virus and other respiratory infections; and inhalers and other device therapies. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Pulmonary Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. Rapid Publication The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of pulmonary therapies. Open Access All articles published by Pulmonary Therapy are open access. Personal Service The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. Digital Features and Plain Language Summaries Pulmonary Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’. For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/ Publication Fees Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €4500/ $5100/ £3650. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. Peer Review Process Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria. At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor. Preprints We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website. Please follow the link for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550 Copyright Pulmonary Therapy''s content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0. Contact For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.